GO:0031931 TORC1 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031931 (TORC1 complex) is a cellular component defined as a protein complex containing at least TOR and Raptor (or their orthologs), which mediates phosphorylation and activation of S6K.
• In Saccharomyces cerevisiae, TORC1 contains Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p.
• TORC1 integrates nutrient, energy, and stress signals to control cell growth, autophagy, and ribosome biogenesis.
• Dysregulation of TORC1 signaling is implicated in cancer, tuberous sclerosis complex, and lysosomal storage disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of TORC1 components and their disease variants.
• Key research methods include Ribo-seq, RNA-seq, proteomics, and imaging to measure TORC1 activity and downstream effects.
Description
The TORC1 complex (GO:0031931) is a central signaling hub that couples nutrient availability to cell growth and proliferation. It is defined as a protein complex that contains at least TOR (target of rapamycin) and Raptor (regulatory-associated protein of TOR), or orthologs of these proteins, in complex with other signaling components, and it mediates the phosphorylation and activation of S6K. In Saccharomyces cerevisiae, the complex contains Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p. Because TORC1 sits at the intersection of nutrient sensing, autophagy, and ribosome biogenesis, it is a major focus for researchers studying growth control, metabolism, and disease. Understanding its composition, regulation, and downstream effects is essential for interpreting genetic and pharmacological perturbations. This article provides a research-grade overview of TORC1 complex biology, its key genes, disease links, and experimental methods, with an emphasis on CRISPR-based approaches for functional validation.
TORC1 complex At A Glance
| GO ID | GO:0031931 |
|---|---|
| GO term | TORC1 complex |
| Ontology | cellular_component |
| Synonym | mTORC1, TORC1, dTORC1, nutrient sensitive complex, rapamycin and nutrient-sensitive TOR complex |
| Major function | Mediates phosphorylation and activation of S6K; integrates nutrient and stress signals to control growth, autophagy, and ribosome biogenesis |
| Yeast components | Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p |
| Mammalian components | mTOR, Raptor, mLST8, and associated proteins |
| Regulation | Responds to amino acids, glucose, energy status, and stress via upstream regulators such as the EGO complex and Rag GTPases |
What Is GO:0031931?
The TORC1 complex is a cellular component defined by the presence of TOR and Raptor (or their orthologs) together with additional signaling components. It functions as a nutrient-sensitive kinase complex that phosphorylates and activates S6K, thereby promoting anabolic processes such as protein synthesis and ribosome biogenesis while inhibiting catabolic processes like autophagy. In yeast, the complex includes Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p.
Why Is TORC1 complex Important in Cell Biology?
TORC1 is a master regulator of cell growth and metabolism, and its dysfunction is linked to cancer, metabolic disorders, and neurodegeneration. Because it controls protein synthesis, autophagy, and ribosome biogenesis, TORC1 activity must be tightly regulated; perturbations in its components or upstream regulators can drive disease. Studying TORC1 complex assembly and function provides mechanistic insight into how cells adapt to nutrient availability and how these pathways go awry in disease.
• TORC1 integrates nutrient and energy signals to control cell growth and proliferation.
• It phosphorylates S6K and other substrates to promote protein synthesis and ribosome biogenesis.
• TORC1 inhibits autophagy under nutrient-rich conditions, and its inactivation triggers autophagic degradation.
• Dysregulated TORC1 signaling is a hallmark of many cancers and is targeted by rapamycin and rapalogs.
• Mutations in TORC1 pathway components cause tuberous sclerosis complex and related disorders.
• TORC1 is involved in the response to lysosomal damage and cystine mobilization.
• It regulates nucleolar function and stress responses.
• TORC1 activity can be monitored by phosphorylation of downstream effectors such as S6K and 4E-BP1.
• CRISPR screens have identified TORC1 components as essential for growth under specific nutrient conditions.
• TORC1 is a key node for pharmacological intervention in cancer and metabolic diseases.
Core Biology of the TORC1 complex
What Happens During TORC1 complex Signaling?
In simple terms: TORC1 acts like a cellular switch that turns on growth when nutrients are available and turns off recycling processes.
TORC1 signaling is initiated by nutrient availability, particularly amino acids and glucose, which are sensed by upstream regulators such as the EGO complex and Rag GTPases. Upon activation, TORC1 phosphorylates downstream substrates including S6K, leading to increased protein synthesis and ribosome biogenesis. Simultaneously, TORC1 inhibits autophagy by phosphorylating components of the autophagic machinery and by activating the Rpd3L complex to deacetylate histones and repress autophagy genes. Under stress conditions, TORC1 activity is downregulated, leading to nucleolar stress responses and cell cycle arrest.
Structure and Composition of TORC1 complex
In simple terms: TORC1 is a multi-protein machine built from TOR, Raptor, and several accessory proteins.
The core of TORC1 consists of the TOR kinase and Raptor (Kog1p in yeast), which together form the minimal functional unit. In Saccharomyces cerevisiae, the complex also contains Lst8p and Tco89p, and either Tor1p or Tor2p. In mammals, the complex includes mTOR, Raptor, mLST8, and additional proteins such as Deptor and PRAS40. Assembly of TORC1 is regulated by nutrient signals and involves the EGO complex at the lysosomal membrane. The complex localizes to the lysosomal surface in mammals and to the vacuolar membrane in yeast, where it interacts with Rag GTPases and other regulators.
Molecular Mechanism of TORC1 complex
In simple terms: TORC1 works by adding phosphate groups to target proteins, which changes their activity.
TORC1 is a serine/threonine kinase that phosphorylates substrates such as S6K and 4E-BP1. The kinase activity of TOR requires association with Raptor and mLST8, which help recruit substrates and stabilize the complex. Phosphorylation of S6K leads to its activation and subsequent phosphorylation of ribosomal protein S6, promoting translation initiation. TORC1 also phosphorylates the Rpd3L complex component to deacetylate Ino80 and H2A.Z, thereby repressing autophagy genes. The activity of TORC1 is controlled by upstream signals including amino acids, glucose, and energy status, which converge on the Rag GTPases and the EGO complex.
Regulation of TORC1 complex
In simple terms: TORC1 is controlled by a network of sensors that tell it whether nutrients are available.
TORC1 activity is positively regulated by amino acids via the EGO complex and Rag GTPases, which recruit TORC1 to the lysosomal membrane where it encounters its activator Rheb. Glucose availability also regulates TORC1 through mechanisms involving the EGO complex and possibly other sensors. Under low leucine conditions, the Whi2-Psr1-Psr2 complex selectively regulates TORC1 and autophagy, distinguishing between different nutrient stresses. Stress conditions such as nucleolar stress can inhibit TORC1, leading to cell cycle arrest and altered ribosome biogenesis. Additionally, lysosomal cystine mobilization shapes TORC1 responses to fasting, linking lysosomal function to nutrient sensing.
Key Genes Involved in GO:0031931 TORC1 complex
The following genes and proteins are core components or regulators of the TORC1 complex, with established roles in its assembly, function, and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Core kinase of TORC1; phosphorylates S6K and 4E-BP1 | Central to growth control; target of rapamycin; frequently studied in cancer |
| RPTOR | Raptor; scaffold protein that recruits substrates to mTOR | Essential for TORC1 assembly and function; knockout causes early lethality |
| MLST8 | mLST8; stabilizes the kinase domain of mTOR | Required for TORC1 activity; studied in structural and functional assays |
| TSC1 | Tuberous sclerosis complex 1; inhibits Rheb | Mutations cause tuberous sclerosis; regulates TORC1 via Rheb |
| TSC2 | Tuberous sclerosis complex 2; GTPase-activating protein for Rheb | Mutations cause tuberous sclerosis; functional assessment of variants |
| RHEB | Small GTPase that activates mTORC1 at the lysosome | Key activator; studied in growth control and cancer |
| RRAGA | Rag GTPase A; recruits TORC1 to lysosome in response to amino acids | Part of the EGO complex; regulates TORC1 localization |
| RRAGB | Rag GTPase B; forms heterodimers with RagC/D | Regulates TORC1 in response to amino acid availability |
| RRAGC | Rag GTPase C; part of the Rag heterodimer | Controls TORC1 recruitment and activation |
| RRAGD | Rag GTPase D; part of the Rag heterodimer | Regulates TORC1 in response to nutrients |
| LAMTOR1 | Component of the EGO complex (ragulator); anchors Rag GTPases to lysosome | Essential for TORC1 activation by amino acids |
| LAMTOR2 | Component of the EGO complex; part of ragulator | Regulates TORC1 signaling and lysosomal positioning |
| LAMTOR3 | Component of the EGO complex; part of ragulator | Required for amino acid sensing and TORC1 activation |
| LAMTOR4 | Component of the EGO complex; part of ragulator | Modulates TORC1 activity |
| LAMTOR5 | Component of the EGO complex; part of ragulator | Regulates TORC1 in response to nutrients |
| RPS6KB1 | S6 kinase 1; direct substrate of TORC1 | Phosphorylated by TORC1; readout of TORC1 activity |
| EIF4EBP1 | 4E-BP1; TORC1 substrate that inhibits translation when unphosphorylated | Phosphorylation by TORC1 relieves inhibition of translation |
| WHI2 | Yeast protein that regulates TORC1 under low leucine | Part of Whi2-Psr1-Psr2 complex; studied in nutrient stress |
How Is TORC1 complex Regulated?
TORC1 complex activity is regulated by a complex network of upstream signals. Amino acids, particularly leucine and arginine, activate TORC1 through the EGO complex and Rag GTPases, which recruit TORC1 to the lysosomal membrane where it is activated by Rheb. Glucose availability also regulates TORC1, and the EGO complex plays a central role in this process. Under low leucine conditions, the Whi2-Psr1-Psr2 complex selectively regulates TORC1 and autophagy, distinguishing leucine stress from general nitrogen depletion. Stress conditions such as nucleolar stress can inhibit TORC1, leading to cell cycle arrest and altered ribosome biogenesis. Additionally, lysosomal cystine mobilization shapes TORC1 responses to fasting, linking lysosomal function to nutrient sensing. These regulatory mechanisms ensure that TORC1 activity is tightly coupled to the cell's metabolic state.
TORC1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSC1 | Tuberous sclerosis complex; hamartomas | TSC1 knockout cell lines; patient-derived iPSCs |
| TSC2 | Tuberous sclerosis complex; functional assessment of variants | TSC2 point mutation knock-in; TSC2 knockout |
| MTOR | Cancer; metabolic disorders | MTOR knockout; point mutation of kinase domain |
| RPTOR | Cancer; growth disorders | RPTOR knockout; conditional knockout |
| LAMTOR1 | Lysosomal positioning; nutrient sensing | LAMTOR1 knockout; tagged knock-in for localization |
TORC1 in Cancer
Hyperactivation of TORC1 signaling is a common feature of many cancers, driven by mutations in upstream regulators such as TSC1, TSC2, or oncogenes like PI3K and AKT. TORC1 promotes cell growth and proliferation by phosphorylating S6K and 4E-BP1, and its inhibition by rapamycin or rapalogs has been explored as a therapeutic strategy. Functional assessment of TSC2 variants has shown that loss of TSC2 function leads to constitutive TORC1 activation, contributing to tumorigenesis in tuberous sclerosis complex.
TORC1 in Tuberous Sclerosis Complex
Tuberous sclerosis complex (TSC) is caused by mutations in TSC1 or TSC2, which encode inhibitors of TORC1 signaling. Loss of TSC1 or TSC2 results in uncontrolled TORC1 activity, leading to benign tumors in multiple organs. Functional studies of TSC2 variants have helped classify their impact on TORC1 signaling, providing insights into disease mechanisms and potential treatments.
TORC1 in Lysosomal Storage and Neurodegeneration
Lysosomal dysfunction and impaired TORC1 signaling are linked to neurodegenerative diseases and lysosomal storage disorders. The endo-lysosomal damage response involves TORC1 regulation, and lysosomal cystine mobilization shapes TORC1 responses to fasting, highlighting the interplay between lysosomal function and nutrient sensing. Dysregulation of these pathways can contribute to neuronal death and disease progression.
TORC1 in Stress and Aging
TORC1 activity is closely tied to stress responses and aging. Inhibition of TORC1 extends lifespan in model organisms and is associated with improved stress resistance. TORC1 regulates nucleolar function, and its downregulation under stress leads to nucleolar stress responses that can affect cell survival. The Whi2-Psr1-Psr2 complex selectively regulates TORC1 under low leucine conditions, linking nutrient stress to autophagy and cell fate.
From TORC1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TORC1 component affect cell growth? | CRISPR knockout of MTOR, RPTOR, or MLST8 in cell lines |
| How do disease-associated mutations affect TORC1 activity? | Point mutation knock-in of TSC2 variants |
| Where does TORC1 localize under nutrient stress? | Tagged knock-in of LAMTOR1 or RPTOR with fluorescent tags |
| Does overexpression of S6K rescue TORC1 loss? | Overexpression of RPS6KB1 in TORC1 knockout background |
| What genes are essential for TORC1 signaling? | CRISPR library screening with readout of S6K phosphorylation |
| How does TORC1 regulate autophagy under low leucine? | Knockout of WHI2 or PSr1/Psr2 in yeast |
How to Study the TORC1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunoblotting for p-S6K | TORC1 kinase activity | Assessing activation state after genetic or drug treatment |
| Ribo-seq | Translation efficiency and ribosome occupancy | Global effects of TORC1 on protein synthesis |
| RNA-seq | Transcriptional changes | Identifying TORC1-regulated genes and pathways |
| Affinity purification-mass spectrometry | Protein-protein interactions | Defining TORC1 composition and interactors |
| Fluorescence microscopy | Subcellular localization | Visualizing TORC1 at lysosome/vacuole |
| CRISPR library screening | Gene essentiality and synthetic lethality | Identifying regulators of TORC1 signaling |
| Phos-tag gel | Phosphorylation status of substrates | Detecting TORC1-dependent phosphorylation |
| Yeast growth assays | Cell growth under nutrient conditions | Testing TORC1 mutants in Saccharomyces |
Measuring TORC1 Activity by Phosphorylation
TORC1 activity is commonly assessed by immunoblotting for phosphorylated S6K (Thr389) and 4E-BP1 (Thr37/46). These readouts reflect the kinase activity of TORC1 and can be used to evaluate genetic or pharmacological perturbations. In yeast, phosphorylation of Sch9 can serve as a readout.
Transcriptomics and Ribo-seq
RNA-seq and Ribo-seq can measure the impact of TORC1 on gene expression and translation. TORC1 promotes ribosome biogenesis and translation, so its inhibition leads to decreased translation of ribosomal proteins and altered transcript levels. Ribo-seq provides codon-level resolution of translation efficiency.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify TORC1 components and interacting proteins. This approach has been used to define the composition of the complex in yeast and mammals. Proximity labeling can also map the TORC1 interactome in live cells.
Imaging and Localization Studies
Fluorescence microscopy of tagged TORC1 components (e.g., GFP-Raptor) allows visualization of lysosomal localization and its regulation by nutrients. Live-cell imaging can track TORC1 dynamics in response to amino acid availability.
How CRISPR Can Be Used to Study GO:0031931 TORC1 complex
Knockout
CRISPR knockout of core TORC1 genes such as MTOR, RPTOR, or MLST8 results in loss of TORC1 function, leading to growth arrest and autophagy induction. Knockout cell lines are valuable for studying the essential roles of these genes and for identifying compensatory pathways. In yeast, deletion of TOR1 or TOR2 has distinct effects, and double knockouts are lethal.
Point Mutation
Point mutations can be introduced to model disease-associated variants, such as TSC2 mutations found in tuberous sclerosis complex. These knock-in models allow functional assessment of specific amino acid changes on TORC1 activity and downstream signaling. Kinase-dead mutations in MTOR can also be generated to dissect catalytic function.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous TORC1 genes enables visualization and biochemical purification of the complex. Tagged knock-in models preserve endogenous regulation and are useful for localization studies. Knock-in of reporter genes under TORC1-responsive promoters can monitor pathway activity.
Overexpression
Overexpression of TORC1 components or downstream substrates such as RPS6KB1 can be achieved by CRISPR-mediated knock-in of strong promoters or by lentiviral delivery. Overexpression models help test sufficiency of a gene in driving growth or resistance to rapamycin. They are also used to rescue knockout phenotypes.
How EDITGENE Supports TORC1 complex Research
Researchers studying TORC1 complex-related genes often need to determine whether a candidate gene is causally involved in TORC1 signaling, how specific mutations affect complex assembly and activity, and whether targeting these genes can reverse disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for TORC1 complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AKT1S1 Knockout HEK293 Cell Line | EDJ-KQ613 | Human | 84335 | Details Get a Quote |
| LARP1 Knockout HEK293 Cell Line | EDJ-KQ2425 | Human | 23367 | Details Get a Quote |
| LARP1 Knockout HCT 116 Cell Line | EDJ-KQ22935 | Human | 23367 | Details Get a Quote |
| LARP1 Knockout HeLa Cell Line | EDJ-KQ22936 | Human | 23367 | Details Get a Quote |
| AKT1S1 Knockout A-549 Cell Line | EDJ-KQ20424 | Human | 84335 | Details Get a Quote |
| AKT1S1 Knockout HCT 116 Cell Line | EDJ-KQ20425 | Human | 84335 | Details Get a Quote |
| AKT1S1 Knockout HeLa Cell Line | EDJ-KQ20426 | Human | 84335 | Details Get a Quote |
| LARP1 Knockout A-549 Cell Line | EDJ-KQ64224 | Human | 23367 | Details Get a Quote |
| MTOR (p.L2303=) Point Mutation in HAP1 Cell Line | EDC03557 | Human | 2475 | Details Get a Quote |
| MTOR (p.S1851=) Point Mutation in HAP1 Cell Line | EDC03558 | Human | 2475 | Details Get a Quote |
| MTOR (c.4253+4718A>G )Point Mutation in HAP1 Cell Line | EDC03559 | Human | 2475 | Details Get a Quote |
Frequently Asked Questions About TORC1 complex
What is the TORC1 complex?
The TORC1 complex (GO:0031931) is a protein complex containing TOR and Raptor (or orthologs) that mediates phosphorylation and activation of S6K, thereby controlling cell growth and metabolism.
What genes are involved in the TORC1 complex?
Core genes include MTOR, RPTOR, and MLST8 in mammals, and TOR1, TOR2, KOG1, LST8, and TCO89 in yeast. Upstream regulators include TSC1, TSC2, RHEB, and Rag GTPases.
What is the function of TORC1?
TORC1 integrates nutrient and energy signals to promote protein synthesis, ribosome biogenesis, and inhibit autophagy, thereby regulating cell growth and proliferation.
How is TORC1 complex regulated?
TORC1 is regulated by amino acids, glucose, and stress via the EGO complex, Rag GTPases, and Rheb. Under low leucine, the Whi2-Psr1-Psr2 complex selectively modulates TORC1.
What diseases are associated with TORC1 dysfunction?
Dysregulated TORC1 signaling is implicated in cancer, tuberous sclerosis complex, lysosomal storage disorders, and neurodegeneration.
How can I study TORC1 complex in the lab?
Common methods include immunoblotting for phosphorylated S6K, Ribo-seq, RNA-seq, proteomics, imaging, and CRISPR knockout or knock-in models.
What is the difference between TORC1 and TORC2?
TORC1 contains Raptor and is sensitive to rapamycin, while TORC2 contains Rictor and is generally rapamycin-insensitive; they have distinct substrates and functions.
Can CRISPR be used to model TORC1-related diseases?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to study TORC1 component function and disease variants such as TSC2 mutations.
What are the key substrates of TORC1?
Major substrates include S6K (RPS6KB1) and 4E-BP1 (EIF4EBP1), whose phosphorylation by TORC1 promotes translation and cell growth.
Where is TORC1 localized in the cell?
TORC1 localizes to the lysosomal membrane in mammals and the vacuolar membrane in yeast, where it interacts with Rag GTPases and Rheb.
Conclusion
The TORC1 complex (GO:0031931) is a central regulator of cell growth and metabolism, integrating nutrient and stress signals to control translation, autophagy, and ribosome biogenesis. Its composition and regulation are conserved from yeast to humans, and its dysfunction is linked to cancer, tuberous sclerosis, and lysosomal disorders. CRISPR-based models, combined with advanced omics and imaging, provide powerful tools to dissect TORC1 biology and identify therapeutic targets. EDITGENE offers comprehensive services to support these studies with validated knockout, point mutation, knock-in, and overexpression models, as well as CRISPR library screening and bioinformatics analysis.
References
- 1. De Virgilio C. 2026. EGO complex at 20: The Rag GTPase-TORC1 nutrient-sensing blueprint.. Mol Cell 86(2):242-257 PMID: 41576914
- 2. Meyer H et al.. 2024. The Endo-Lysosomal Damage Response.. Annu Rev Biochem 93(1):367-387 PMID: 38594929
- 3. Battaglioni S et al.. 2022. mTOR substrate phosphorylation in growth control.. Cell 185(11):1814-1836 PMID: 35580586
- 4. Hoogeveen-Westerveld M et al.. 2013. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.. Hum Mutat 34(1):167-75 PMID: 22903760
- 5. Jouandin P et al.. 2022. Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting.. Science 375(6582):eabc4203 PMID: 35175796
- 6. Matos-Perdomo E et al.. 2018. TORC1, stress and the nucleolus.. Aging (Albany NY) 10(5):857-858 PMID: 29788001
- 7. Wang Y et al.. 2025. The Whi2-Psr1-Psr2 complex selectively regulates TORC1 and autophagy under low leucine conditions but not nitrogen depletion.. Autophagy 21(8):1700-1716 PMID: 40103213
- 8. Li X et al.. 2023. The TORC1 activates Rpd3L complex to deacetylate Ino80 and H2A.Z and repress autophagy.. Sci Adv 9(10):eade8312 PMID: 36888706
